Skip to main content
COVID Update

Per Governor Baker's new guidelines regarding mask policies, we will continue to require face masks in our office for both patients and staff at all times. Below is a copy of his new policy; Effective May 29, 2021, face coverings will continue to be required for both vaccinated and unvaccinated individuals at all times in the following locations, subject to the exemptions listed below: In Health Care Facilities and Provider Offices, defined as healthcare facilities or providers licensed or operated by the Commonwealth including nursing homes, rest homes, emergency medical services, hospitals, doctor’s office, urgent care settings, community health centers, vaccination sites, behavioral health clinics, and Bureau of Substance and Addiction Services (BSAS) facilities. This requirement applies to patients and staff.

We’re located in the Berkshires in Western Massachusetts on 217 South Street in Pittsfield.

Home » Eye Care Services » Your Eye Health » Eye Diseases » Diabetes and Eyesight » Treatment for Diabetic Retinopathy

Treatment for Diabetic Retinopathy

95% of people diagnosed with diabetic retinopathy, if treated promptly, can avoid significant vision loss.

Laser photocoagulation treatment seals off blood vessels that are leaking into the eye, and stops new blood vessels from growing. This laser treatment only takes a few moments, and is painless.

Sometimes in diabetic retinopathy blood leaks into the vitreous humor in the eye, clouding vision. Some eye doctors wait before choosing treatment, as the blood may dissipate by itself. Another treatment option is a vitrectomy, which removes blood that has already leaked into the vitreous humor.

To improve the supply of blood to the core inner portion of the retina, a laser may be used to destroy tissue on the outside of the retina which is not essential for basic vision. This procedure is used to save vision.

Lucentis is a medication that is administered by an eye doctor using injections. This medication was approved by the FDA in 2015, and is the first non-laser treatment approved by the FDA. The FDA is currently reviewing several other non-laser treatments for diabetic retinopathy.

x

Holiday Hours

We will be closed on Monday, May 31st for Memorial Day.